Israel-based pharmaceutical company Avraham Pharmaceuticals secured $3m in financing yesterday from investors including Clal Biotechnology Industries (CBI), the corporate venturing unit for investment holding company Clal.
Participants in the round also included Yissum Research Development Company, the technology transfer unit belonging to the Hebrew University of Jerusalem, venture capital firm Pontifax and the Technion Research and Development Foundation Ltd., a subsidiary of the government-backed Israel Institute of Technology.
CBI, Yissum and Pontifax previously invested $9m in Avraham’s series A round,…
